Abstract: Patient activity and heart rate (HR) are monitored. For each of a plurality of time periods, periods of patient exercise and/or patient activity, if any, are detected based on the monitored patient activity and HR and an activity threshold. A cumulative duration of exercise and/or a cumulative duration of activity is/are determined for each time period, and the peak exercise HR for each period of patient exercise is detected. Information is stored, including duration information indicative of the cumulative duration of exercise and/or the cumulative duration of activity for each time period, and peak exercise information associated with the period of patient exercise during which the highest peak exercise HR occurred for each time period.

Abstract: An electromagnetic interference (EMI) filter is provided to attenuate potentially damaging high frequency electromagnetic interference from interfering with the operation of a hermetically sealed implantable medical device. In one embodiment, the EMI filter is joined to a bypass unit that is configured to provide an energy path for the delivery of an energy pulse. The bypass unit, in one embodiment, may include a non-linear device in parallel with an impedance component. The non-linear device can be a DIAC, a MOSFET, or any other non-linear semiconductor array. The EMI filter may be located within the header assembly, the feedthrough assembly, or located proximate to a pulse generator along the energy delivery path.

Abstract: Embodiments of the present invention relate to implantable systems, and methods for use therewith, for monitoring myocardial mechanical stability based on a signal that is indicative of mechanical functioning of a patient's heart for a plurality of consecutive beats. Certain embodiments use time domain techniques, while other embodiments use frequency domain techniques, to monitor myocardial mechanical stability. In certain embodiments the patient's heart is paced using a patterned pacing sequence that repeats every N beats. In other embodiments, the patient's heart need not be paced. This abstract is not intended to be a complete description of, or limit the scope of, the invention.

Abstract: Implantable systems, and methods for use therein, perform at least one of a cardiac assessment and an autonomic assessment. Premature atrial contractions (PACs) are induced to thereby cause corresponding premature contractions in the ventricles. Short-term fluctuations in cardiac intervals, that follow the premature contractions in the ventricles caused by the induced PACs, are monitored. At least one of a cardiac assessment and an autonomic assessment is performed based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs. This can include assessing a patient's risk of sudden cardiac death (SCD), assessing a patient's autonomic tone and/or detecting myocardial ischemic events based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs.

Abstract: Filtering components are provided for reducing heating within pacing/sensing leads of a pacemaker or other implantable medical device that occurs due to induced loop currents during magnetic resonance imaging (MRI) procedures. In one example, an inductive winding is provided around a non-conducting central portion of a shaft that interconnects a tip electrode of the lead to an inner coil conductor of the lead. By mounting the inductive winding to the shaft, inductive signal filtering can be readily provided so as to reduce tip heating, without requiring the incorporation of a lengthy, bulky inductor along the length of the lead. Capacitive elements may also be incorporated within the shaft to provide for LC filtering. In another example, the non-conducting central portion of the shaft is omitted. Instead, the conducting shaft end portions are interconnected by a stiff inductive winding, which functions as an air coil.

Abstract: Time periods such as PVAB and PVARP are defined based on data acquired during real-time tests. For example, data may be collected during a real-time test that determines a sensing threshold or during a real-time test that determines a capture threshold. Time period information may then be derived based on correlations between the timing of far-field events and/or retrograde conduction derived from the acquired data and the timing of sensed or paced ventricular events. In some cases, the derived time period information may be used to provide timing recommendations for initial programming of an implantable device.

Abstract: Techniques are provided for detecting atrial events that might be hidden due to the operation of a post-ventricular atrial blanking (PVAB) interval or other atrial channel blanking interval. In one example, candidate atrial events are identified within signals occurring during the PVAB interval. Then, a determination is made as to whether the candidate atrial event is a true atrial event based on a comparison of characteristics of the candidate atrial event with characteristics of prior known atrial events within the patient. By comparing the characteristics of the “hidden” event with the characteristics of prior known atrial events within the patient, a quick and accurate determination can be made whether the event should be counted as a P-wave. In this manner, hidden atrial arrhythmias can be detected and mode switch oscillations can be reduced or eliminated.

Abstract: Disclosed herein is an implantable pulse generator. The implantable pulse generator may include a header, a can and a feedthru. The header may include a lead connector block electrically coupled to a first conductor. The can may be coupled to the header and include a wall and an electronic component electrically coupled to a second conductor and housed within the wall. The feedthru may be mounted in the wall and include a header side with a first electrically conductive tab and a can side with a second electrically conductive tab electrically coupled to the first tab. The first tab is electrically coupled to the first conductor and the second tab is electrically coupled to the second conductor.

Abstract: An implantable cardioverter defibrillator (ICD) including a set of leads having electrodes disposed therein. The electrodes may include a weld electrode connected to an internal wire of the lead and the ICD and a tip electrode. The tip electrode may have a set of grooves or cut out regions in its outer surface to provide edge effects for currents applied through the tip electrode. The grooves or cut out regions may form gaps in the surface of the tip electrode exposing a medical compound that is housed within the tip electrode. The medical compound may elute through the gaps.

Abstract: Disclosed herein is an implantable pulse generator. The implantable pulse generator may include a header, a can and a feedthru. The header may include a lead connector block electrically coupled to a first conductor. The can may be coupled to the header and include a wall and an electronic component electrically coupled to a second conductor and housed within the wall. The feedthru may be mounted in the wall and include a header side with a first electrically conductive tab and a can side with a second electrically conductive tab electrically coupled to the first tab. The first tab is electrically coupled to the first conductor and the second tab is electrically coupled to the second conductor.

Abstract: A cardiac rhythm management apparatus includes a proximal housing, a distal housing and a lead. The proximal housing includes a first energy storage device. The distal module is implantable within a patient's heart, and includes a second energy storage device, at least one electrode, and a control module. The control module controls the delivery of at least one electrical stimulus from the second energy storage device to a location in communication with the patient's heart. The lead connects the proximal housing to the distal module and is configured to communicate one or more digital signals between the proximal housing and the distal module.

Abstract: An exemplary implantable device includes an emitter to emit radiation to illuminate a portion of the stomach and a detector to detect emitted radiation reflected by the portion of the stomach where a contraction of the stomach alters the reflected radiation. For example, during contraction, blood is excluded from the contracting region of the stomach and the stomach becomes less red in color. An exemplary method includes illuminating a portion of the gastrointestinal tract, detecting a change in illumination received by a detector where the change in illumination is responsive to a contraction of the gastrointestinal tract. Various other methods, devices, systems, etc., are also disclosed.

Abstract: Anode foil, preferably aluminum anode foil, is etched using a process of treating the foil in an electrolyte bath composition comprising a sulfate and a halide, such as sodium chloride. The anode foil is etched in the electrolyte bath composition by passing a charge through the bath. The etched anode foil is suitable for use in an electrolytic capacitor.

Abstract: Disclosed herein is a tool for implanting a medical lead. In one embodiment, the tool includes a body, an electrode, and a conductor. The body includes a distal end and a proximal end. The electrode is supported by the body. The conductor is in electrical contact with the electrode and extends along the body from the electrode to the proximal end. The electrode and conductor form an electrically conductive path that extends from a surface of the electrode to a proximal most point of the conductor on the body. The electrical resistance of the electrically conductive path is at least approximately 100 Ohms.

Abstract: An implantable cardiac system including an implantable cardiac stimulation device provides a heart activity signal of a heart facilitating measurement of slowly changing electrogram features. The system comprises at least one implantable electrode arrangement that senses cardiac electrical activity and provides an intracardiac electrogram signal, a first high pass filter that filters the electrogram and an equalizer that filters the filtered electrogram signal. The equalizer has a transfer function that is non-decreasing for frequencies up to a lower frequency breakpoint that is less than the upper frequency breakpoint, decreasing for frequencies between the lower frequency breakpoint and the upper frequency breakpoint, and generally flat for frequencies above the upper frequency breakpoint through a bandpass region of interest.

Abstract: An exemplary method includes delivering an electrical signal to a first position in or adjacent to a cardiac chamber; sensing a potential generated by the delivered electrical signal at a second position; and determining a parameter based, at least in part, on the sensing wherein the parameter relates to cardiac geometry. Other exemplary methods, devices and/or systems are also disclosed.

Abstract: Disclosed herein is an implantable medical lead for coupling to an implantable pulse generator and configured for improved MRI safety. In one embodiment, the lead includes a tubular body, an electrode, an electrical conductor, and a shield layer. The tubular body includes a proximal end and a distal end. The electrode is operably coupled to the tubular body near the distal end. The electrical conductor extends distally through the body from the proximal end and electrically connects to the electrode. The shield layer extends through the tubular body between the proximal and distal ends. The shield layer is configured to reduce an amount of current induced in the electrical conductor when present in an electromagnetic field as compared to the current that would be induced in the electrical conductor absent the shield layer.

Abstract: Detection of atrial fibrillation involves detecting a plurality of ventricular events and obtaining a series of probabilities of AF, each corresponding to a probability of AF for a different beat window having a plurality of ventricular events. AF onset is detected when one or each of a plurality of consecutive AF probabilities satisfies an AF trigger threshold. AF termination is detected when one or each of a plurality of consecutive AF probabilities does not satisfy the AF trigger threshold. A probability of AF is obtained using one or more of a probability of AF that is based on the presence of irregularity of the ventricular events (PMC); a probability of AF that is based on variances of R-R intervals of the ventricular events (PVAR); and/or a combination of these probabilities (PCOMBINED).

Abstract: A method and system are provided for providing coordinated ventricular overdrive and triggered pacing through an implantable system. A lead senses signals from a heart to obtain sensed signals representative of tachycardia occurring in at least one chamber of the heart. The lead includes an electrode. A control module detects tachycardia in at least one chamber of the heart and based thereon, initiates an overdrive pacing mode and a triggered pacing mode. The control module controls delivery of overdrive pacing pulses through the electrode to a first chamber of the heart in accordance with the overdrive pacing mode. The control module controls delivery of a triggered pacing pulse through the electrode to the first chamber of the heart in accordance with the triggered pacing mode. The triggered pacing pulse is temporally interspersed with the overdrive pacing pulses. The triggered pacing pulse may be delivered at a time that is independent of, and unrelated to, the timing of the overdrive pacing pulses.

Abstract: An exemplary method includes performing a capture threshold assessment using a bipolar electrode configuration, deciding if capture occurred for a maximum energy value of the capture threshold assessment and, if capture did not occur, then performing a lead impedance test for the lead associated with the bipolar electrode configuration. Such a test may aim to detect an insulation defect and/or a conductor defect. Other exemplary methods, devices, systems, etc., are also disclosed.